التفاصيل البيبلوغرافية
| العنوان: |
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study. |
| المؤلفون: |
Aussedat, Guillaume, Maucort-Boulch, Delphine, Rey, Philippe, Safar, Violaine, Karlin, Lionel, Elsensohn, Mad Helenie, Bachy, Emmanuel, Lebras, Laure, Favier, Bertrand, Vantard, Nicolas, Ghergus, Dana, Golfier, Camille, Sesques, Pierre, Lazareth, Anne, Lequeu, Hélène, Ferrant, Emmanuelle, Salles, Gilles, Nicolas-Virelizier, Emmanuelle, Ghesquieres, Hervé |
| المصدر: |
Leukemia & Lymphoma; Mar2022, Vol. 63 Issue 3, p599-607, 9p |
| مصطلحات موضوعية: |
DIFFUSE large B-cell lymphomas, IFOSFAMIDE, RITUXIMAB, STEM cell transplantation, ETOPOSIDE |
| مستخلص: |
We retrospectively reviewed for 72 relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) patients ineligible for autologous stem-cell transplantation (ASCT) treated between 2004 and 2017, efficacy and safety profile of rituximab (375 mg/m2) in combination with etoposide (300 mg/m2) and ifosfamide (1500 mg/m2) at 2, 3, or 4-week intervals. Median age was 79 years (range, 64–92). The median number of previous line was 1 (range 1–8). Patients received a median of six cycles (1–12). Fourteen patients (19%) presented partial and 14 complete responses (19%). Among the 369 cycles, nine patients developed febrile neutropenia (13%), 14 a grade 3–4 neutropenia (19%), 7 a grade 3–4 thrombocytopenia (10%) without grade 3–4 non-hematological toxicity. With a median follow up of 7.8 months, the median progression-free survival, overall survival, and duration of response were 4.4 months, 9.4 months, and 12 months, respectively. This regimen represents a therapeutic option in R/R DLBCL patients ineligible to ASCT. [ABSTRACT FROM AUTHOR] |
|
Copyright of Leukemia & Lymphoma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
